Rear-fanged snake venoms: an untapped source of novel compounds and potential drug leads
- Autores
- Saviola, Anthony J.; Peichoto, Myriam Carolina; Machessy, Stephen P.
- Año de publicación
- 2014
- Idioma
- inglés
- Tipo de recurso
- artículo
- Estado
- versión publicada
- Descripción
- Animal venoms represent a diverse source of potentially valuable therapeutic compounds due to the high specificity and the potent biological activity of many toxins. Snake venom toxins, particularly disintegrins and proteases from viper venoms, have yielded therapeutics with anti-cancer and hemostatic dysfunction activities. However, venoms from rear-fanged ??colubrid?? snakes have rarely been analyzed from the perspective of potential lead compound development. Here, we discuss recent progress in the analysis of these venoms, focusing on several studies of specific venom components as well as transcriptomic and proteomic surveys. Currently available ?omic technologies largely circumvent the problematic low venom yields of most rear-fanged snakes, and because their basic biology is often very different from the well-studied front-fanged snakes, there is great potential for novel compound discovery in their venoms.
Animal venoms represent a diverse source of potentially valuable therapeutic compounds due to the high specificity and the potent biological activity of many toxins. Snake venom toxins, particularly disintegrins and proteases from viper venoms, have yielded therapeutics with anti-cancer and hemostatic dysfunction activities. However, venoms from rear-fanged “colubrid” snakes have rarely been analyzed from the perspective of potential lead compound development. Here, we discuss recent progress in the analysis of these venoms, focusing on several studies of specific venom components as well as transcriptomic and proteomic surveys. Currently available –omic technologies largely circumvent the problematic low venom yields of most rear-fanged snakes, and because their basic biology is often very different from the well-studied front-fanged snakes, there is great potential for novel compound discovery in their venoms.
Fil: Saviola, Anthony J.. Univeristy Of Northem Colorado; Estados Unidos
Fil: Peichoto, Myriam Carolina. Ministerio de Salud. Instituto Nacional de Medicina Tropical; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Nordeste; Argentina
Fil: Machessy, Stephen P.. Univeristy Of Northem Colorado; Estados Unidos - Materia
-
Colubrid
Venom
Protein
Structure/Function - Nivel de accesibilidad
- acceso abierto
- Condiciones de uso
- https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
- Repositorio
- Institución
- Consejo Nacional de Investigaciones Científicas y Técnicas
- OAI Identificador
- oai:ri.conicet.gov.ar:11336/17030
Ver los metadatos del registro completo
id |
CONICETDig_1f3de8b4e0031958b37799ef2c84b11b |
---|---|
oai_identifier_str |
oai:ri.conicet.gov.ar:11336/17030 |
network_acronym_str |
CONICETDig |
repository_id_str |
3498 |
network_name_str |
CONICET Digital (CONICET) |
spelling |
Rear-fanged snake venoms: an untapped source of novel compounds and potential drug leadsSaviola, Anthony J.Peichoto, Myriam CarolinaMachessy, Stephen P.ColubridVenomProteinStructure/Functionhttps://purl.org/becyt/ford/1.6https://purl.org/becyt/ford/1Animal venoms represent a diverse source of potentially valuable therapeutic compounds due to the high specificity and the potent biological activity of many toxins. Snake venom toxins, particularly disintegrins and proteases from viper venoms, have yielded therapeutics with anti-cancer and hemostatic dysfunction activities. However, venoms from rear-fanged ??colubrid?? snakes have rarely been analyzed from the perspective of potential lead compound development. Here, we discuss recent progress in the analysis of these venoms, focusing on several studies of specific venom components as well as transcriptomic and proteomic surveys. Currently available ?omic technologies largely circumvent the problematic low venom yields of most rear-fanged snakes, and because their basic biology is often very different from the well-studied front-fanged snakes, there is great potential for novel compound discovery in their venoms.Animal venoms represent a diverse source of potentially valuable therapeutic compounds due to the high specificity and the potent biological activity of many toxins. Snake venom toxins, particularly disintegrins and proteases from viper venoms, have yielded therapeutics with anti-cancer and hemostatic dysfunction activities. However, venoms from rear-fanged “colubrid” snakes have rarely been analyzed from the perspective of potential lead compound development. Here, we discuss recent progress in the analysis of these venoms, focusing on several studies of specific venom components as well as transcriptomic and proteomic surveys. Currently available –omic technologies largely circumvent the problematic low venom yields of most rear-fanged snakes, and because their basic biology is often very different from the well-studied front-fanged snakes, there is great potential for novel compound discovery in their venoms.Fil: Saviola, Anthony J.. Univeristy Of Northem Colorado; Estados UnidosFil: Peichoto, Myriam Carolina. Ministerio de Salud. Instituto Nacional de Medicina Tropical; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Nordeste; ArgentinaFil: Machessy, Stephen P.. Univeristy Of Northem Colorado; Estados UnidosTaylor2014-07info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/17030Saviola, Anthony J.; Peichoto, Myriam Carolina; Machessy, Stephen P.; Rear-fanged snake venoms: an untapped source of novel compounds and potential drug leads; Taylor; Toxin Reviews; 33; 4; 7-2014; 185-2011556-95431556-9551enginfo:eu-repo/semantics/altIdentifier/url/http://www.tandfonline.com/doi/full/10.3109/15569543.2014.942040info:eu-repo/semantics/altIdentifier/doi/10.3109/15569543.2014.942040info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-09-03T10:11:51Zoai:ri.conicet.gov.ar:11336/17030instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-09-03 10:11:51.646CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse |
dc.title.none.fl_str_mv |
Rear-fanged snake venoms: an untapped source of novel compounds and potential drug leads |
title |
Rear-fanged snake venoms: an untapped source of novel compounds and potential drug leads |
spellingShingle |
Rear-fanged snake venoms: an untapped source of novel compounds and potential drug leads Saviola, Anthony J. Colubrid Venom Protein Structure/Function |
title_short |
Rear-fanged snake venoms: an untapped source of novel compounds and potential drug leads |
title_full |
Rear-fanged snake venoms: an untapped source of novel compounds and potential drug leads |
title_fullStr |
Rear-fanged snake venoms: an untapped source of novel compounds and potential drug leads |
title_full_unstemmed |
Rear-fanged snake venoms: an untapped source of novel compounds and potential drug leads |
title_sort |
Rear-fanged snake venoms: an untapped source of novel compounds and potential drug leads |
dc.creator.none.fl_str_mv |
Saviola, Anthony J. Peichoto, Myriam Carolina Machessy, Stephen P. |
author |
Saviola, Anthony J. |
author_facet |
Saviola, Anthony J. Peichoto, Myriam Carolina Machessy, Stephen P. |
author_role |
author |
author2 |
Peichoto, Myriam Carolina Machessy, Stephen P. |
author2_role |
author author |
dc.subject.none.fl_str_mv |
Colubrid Venom Protein Structure/Function |
topic |
Colubrid Venom Protein Structure/Function |
purl_subject.fl_str_mv |
https://purl.org/becyt/ford/1.6 https://purl.org/becyt/ford/1 |
dc.description.none.fl_txt_mv |
Animal venoms represent a diverse source of potentially valuable therapeutic compounds due to the high specificity and the potent biological activity of many toxins. Snake venom toxins, particularly disintegrins and proteases from viper venoms, have yielded therapeutics with anti-cancer and hemostatic dysfunction activities. However, venoms from rear-fanged ??colubrid?? snakes have rarely been analyzed from the perspective of potential lead compound development. Here, we discuss recent progress in the analysis of these venoms, focusing on several studies of specific venom components as well as transcriptomic and proteomic surveys. Currently available ?omic technologies largely circumvent the problematic low venom yields of most rear-fanged snakes, and because their basic biology is often very different from the well-studied front-fanged snakes, there is great potential for novel compound discovery in their venoms. Animal venoms represent a diverse source of potentially valuable therapeutic compounds due to the high specificity and the potent biological activity of many toxins. Snake venom toxins, particularly disintegrins and proteases from viper venoms, have yielded therapeutics with anti-cancer and hemostatic dysfunction activities. However, venoms from rear-fanged “colubrid” snakes have rarely been analyzed from the perspective of potential lead compound development. Here, we discuss recent progress in the analysis of these venoms, focusing on several studies of specific venom components as well as transcriptomic and proteomic surveys. Currently available –omic technologies largely circumvent the problematic low venom yields of most rear-fanged snakes, and because their basic biology is often very different from the well-studied front-fanged snakes, there is great potential for novel compound discovery in their venoms. Fil: Saviola, Anthony J.. Univeristy Of Northem Colorado; Estados Unidos Fil: Peichoto, Myriam Carolina. Ministerio de Salud. Instituto Nacional de Medicina Tropical; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Nordeste; Argentina Fil: Machessy, Stephen P.. Univeristy Of Northem Colorado; Estados Unidos |
description |
Animal venoms represent a diverse source of potentially valuable therapeutic compounds due to the high specificity and the potent biological activity of many toxins. Snake venom toxins, particularly disintegrins and proteases from viper venoms, have yielded therapeutics with anti-cancer and hemostatic dysfunction activities. However, venoms from rear-fanged ??colubrid?? snakes have rarely been analyzed from the perspective of potential lead compound development. Here, we discuss recent progress in the analysis of these venoms, focusing on several studies of specific venom components as well as transcriptomic and proteomic surveys. Currently available ?omic technologies largely circumvent the problematic low venom yields of most rear-fanged snakes, and because their basic biology is often very different from the well-studied front-fanged snakes, there is great potential for novel compound discovery in their venoms. |
publishDate |
2014 |
dc.date.none.fl_str_mv |
2014-07 |
dc.type.none.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion http://purl.org/coar/resource_type/c_6501 info:ar-repo/semantics/articulo |
format |
article |
status_str |
publishedVersion |
dc.identifier.none.fl_str_mv |
http://hdl.handle.net/11336/17030 Saviola, Anthony J.; Peichoto, Myriam Carolina; Machessy, Stephen P.; Rear-fanged snake venoms: an untapped source of novel compounds and potential drug leads; Taylor; Toxin Reviews; 33; 4; 7-2014; 185-201 1556-9543 1556-9551 |
url |
http://hdl.handle.net/11336/17030 |
identifier_str_mv |
Saviola, Anthony J.; Peichoto, Myriam Carolina; Machessy, Stephen P.; Rear-fanged snake venoms: an untapped source of novel compounds and potential drug leads; Taylor; Toxin Reviews; 33; 4; 7-2014; 185-201 1556-9543 1556-9551 |
dc.language.none.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
info:eu-repo/semantics/altIdentifier/url/http://www.tandfonline.com/doi/full/10.3109/15569543.2014.942040 info:eu-repo/semantics/altIdentifier/doi/10.3109/15569543.2014.942040 |
dc.rights.none.fl_str_mv |
info:eu-repo/semantics/openAccess https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ |
eu_rights_str_mv |
openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ |
dc.format.none.fl_str_mv |
application/pdf application/pdf |
dc.publisher.none.fl_str_mv |
Taylor |
publisher.none.fl_str_mv |
Taylor |
dc.source.none.fl_str_mv |
reponame:CONICET Digital (CONICET) instname:Consejo Nacional de Investigaciones Científicas y Técnicas |
reponame_str |
CONICET Digital (CONICET) |
collection |
CONICET Digital (CONICET) |
instname_str |
Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.name.fl_str_mv |
CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.mail.fl_str_mv |
dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar |
_version_ |
1842270173365534720 |
score |
13.13397 |